— Catálogo

Muscle & Recovery

This category brings together two families that research approaches by different routes: peptides studied in tissue repair and secretagogues, which act on the growth hormone axis. Knowing which family a compound belongs to is the first thing that organizes the choice.

Showing 1–12 of 13 results

Tissue-repair peptides

BPC-157 is the most documented of the group. It derives from a protein in gastric juice and is studied for its relationship with angiogenesis through the VEGF pathway; one of its most cited properties is stability in acidic media. TB-500 addresses another route: a 7-amino-acid fragment of thymosin beta-4 that acts on actin dynamics, on which cell migration depends. Because the two pathways do not overlap, combined formulations exist, such as the TB4 Blend with BPC-157. KPV, a tripeptide derived from alpha-MSH, is investigated through the NF-κB pathway.

Secretagogues and GHRH analogs

Here the key distinction is the receptor. GHRH analogs such as CJC-1295 act on the GHRH receptor; secretagogues such as Ipamorelin and GHRP-6 act on the ghrelin receptor. Since the targets differ, both can be activated at once, which is where the combined formulations come from. Within the GHRH analogs, the DAC version binds albumin and sustains elevation for days, while the no-DAC version produces a brief pulse that reproduces the physiological pattern.

Completing the category: IGF-1 LR3, an analog modified to escape the binding proteins that regulate native IGF-1, and Follistatin 344, a glycoprotein that antagonizes myostatin.

Products in this category

All products in this category are intended exclusively for scientific research and laboratory development. They are not medicines, hold no INVIMA sanitary registration and are not fit for human or animal consumption.